INCREASED EXPRESSION OF PENTRAXIN 3 IN
PLACENTAL TISSUES FROM PATIENTS WITH
UNEXPLAINED RECURRENT PREGNANCY LOSS
Zeybek S1,*, Tepeli E2, Cetin GO3, Caner V3, Senol H4, Yildirim B2, Bagci G3
*Corresponding Author: Selcan Zeybek, M.D., Department of Medical Genetics, Erzurum Regional
Training and Research Hospital, Cat Volu Street, 25070, Erzurum, Turkey. Tel.: +90-506-399-2644.
Fax: +90-442-232-5025. E-mail: selcankesan@yahoo.com
page: 21
|
|
REFERENCES
1. Practice Committee of the American Society for Reproductive
Medicine. Definitions of infertility and
recurrent pregnancy loss. Fertil Steril. 2013; 99(1): 63.
2. Jaslow CR, Carney JL, Kutteh WH. Diagnostic factors
identified in 1020 women with two versus three
or more recurrent pregnancy losses. Fertil Steril.
2010; 93(4): 1234-1243.
3. Ford HB, Schust DJ. Recurrent pregnancy loss: Etiology,
diagnosis, and therapy. Rev Obstet Gynecol.
2009; 2(2): 76-83.
4. Jeve YB, Davies W. Evidence-based management
of recurrent miscarriages. J Hum Reprod Sci. 2014;
7(3): 159-169.
5. Christiansen OB. Reproductive immunology. Mol
Immunol. 2013; 55(1): 8-15.
6. Kalagiri RR, Carder T, Choudhury S, Vora N, Ballard
AR, Govande V, et al. Inflammation in complicated
pregnancy and its outcome. Am J Perinatol. 2016;
33(14): 1337-1356.
7. Mor G, Cardenas I, Abrahams V, Guller S. Inflammation
and pregnancy: The role of the immune system
at the implantation site. Ann NY Acad Sci. 2011;
1221(1): 80-87.
8. Doni A, Garlanda C, Mantovani A. Innate immunity,
hemostasis and matrix remodeling: PTX3 as a link.
Semin Immunol. 2016; 28(6): 570-577.
9. Bottazzi B, Doni A, Garlanda C, Mantovani A. An
integrated view of humoral innate immunity: pentraxins
as a paradigm. Annu Rev Immunol. 2010; 28:
157-183.
10. Garlanda C, Maina V, Cotena A, Moalli F. The soluble
pattern recognition receptor pentraxin-3 in innate
immunity, inflammation and fertility. J Reprod Immunol.
2009; 83(1-2): 128-133.
11. Casula M, Montecucco F, Bonaventura A, Liberale
L, Vecchié A, Dallegri F, et al. Update on the role
of Pentraxin 3 in atherosclerosis and cardiovascular
diseases. Vascul Pharmacol. 2017; 99: 1-12.
12. Larsson A, Palm M, Helmersson J, Axelsson O. Pentraxin
3 values during normal pregnancy. Inflammation.
2011; 34(5): 448-451.
13. Lekva T, Michelsen AE, Bollerslev J, Norwitz ER,
Aukrust P, Henriksen T, et al. Low circulating pentraxin
3 levels in pregnancy is associated with gestational
diabetes and increased apoB/apoA ratio: A
5-year follow-up study. Cardiovasc Diabetol. 2016;
15: 23.
14. Rovere-Querini P, Antonacci S, Dell’Antonio G,
Angeli A, Almirante G, Cin ED. Plasma and tissue
expression of the long pentraxin 3 during normal
pregnancy and preeclampsia. Obstet Gynecol. 2006;
108(1): 148-155.
15. Willeke F, Assad A, Findeisen P, Schromm E, Grobholz
R, von Gerstenbergk B, et al. Overexpression of
a member of the pentraxin family (PTX3) in human
soft tissue liposarcoma. Eur J Cancer. 2006; 42(15):
2639-2646.
16. Jaillon S, Bonavita E, Gentile S, Rubino M, Laface
I, Garlanda C, et al. The long pentraxin PTX3 as a
key component of humoral innate immunity and a
candidate diagnostic for inflammatory diseases. Int
Arch Allergy Immunol. 2014; 165(3): 165-178.
17. Giacomini A, Ghedini GC, Presta M, Ronca, R. Long
pentraxin 3: A novel multifaceted player in cancer.
Biochim Biophys Acta. 2018; 1869(1): 53-63.
18. Cozzi V, Garlanda C, Nebuloni M, Maina V, Martinelli
A, Calabrese S, et al. PTX3 as a potential endothelial
dysfunction biomarker for severity of preeclampsia
and IUGR. Placenta. 2012; 33(12): 1039-1044.
19. Zhou P, Luo X, Qi HB, Zong WJ, Zhang H, Liu DD, et
al. The expression of pentraxin 3 and tumor necrosis
factor-α is increased in preeclamptic placental tissue
and maternal serum. Inflamm Res. 2012; 61(9): 1005-
1012.
20. Akolekar R, Casagrandi D, Livanos P, Tetteh A,
Nicolaides KH. Maternal plasma pentraxin 3 at 11
to 13 weeks of gestation in hypertensive disorders of
pregnancy. Prenat Diagn. 2009; 29(10): 934-938.
21. Baschat AA, Kasdaglis TL, Aberdeen GW, Turan
OM, Kopelman JL, Atlas R, et al. Serum pentraxin-3
levels at 11 to 14 weeks’ gestation: Association with
maternal and placental characteristics. Am J Obstet
Gynecol. 2009; 201(3): 298.e1-298.e6.
22. Cetin I, Cozzi V, Papageorghiou AT, Maina V, Montanelli
A, Garlanda C, et al. First trimester PTX3 levels
in women who subsequently develop preeclampsia
and fetal growth restriction. Acta Obstet Gynecol
Scand. 2009; 88(7): 846-849.
23. Tranguch S, Chakrabarty A, Guo Y, Wang H, Dey
SK. Maternal pentraxin 3 deficiency compromises
implantation in mice. Biol Reprod. 2007; 77(3): 425-
432.
24. Popovici RM, Betzler NK, Krause MS, Luo M,
Jauckus J, Germeyer A, et al. Gene expression profiling
of human endometrial-trophoblast interaction
in a coculture model. Endocrinology. 2006; 147(12):
5662-5675. 25. Hess AP, Hamilton AE, Talbi S, Dosiou C, Nyegaard
M, Nayak N, et al. Decidual stromal cell response to
paracrine signals from the trophoblast: Amplification
of immune and angiogenic modulators. Biol Reprod.
2007; 76(1): 102-117.
26. Cruciani L, Romero R, Vaisbuch E, Kusanovic JP,
Chaiworapongsa T, Mazaki-Tovi S, et al. Pentraxin
3 in maternal circulation: An association with preterm
labor and preterm PROM, but not with intra-amniotic
infection/inflammation. J Matern Fetal Neonatal Med.
2010; 23(10): 1097-1105.
27. Assi F, Fruscio R, Bonardi C, Ghidini A, Allavena P,
Mantovani A, et al. Pentraxin 3 in plasma and vaginal
fluid in women with preterm delivery. Br J Obstet
Gynaecol. 2007; 114(2): 143-147.
28. Jo YS, Cheon JY, Ahn JW, Kim Y, Lee GSR. Pentraxin
3 and lipid profile status in pregnancy. J Obstet
Gynaecol. 2017; 37(3): 727-730.
29. Ibrahim MI, Harb HM, Ellaithy MI, Elkabarity RH,
Abdelgwad MH. First trimester assessment of pentraxin-
3 levels in women with primary unexplained
recurrent pregnancy loss. Eur J Obstet Gynecol Reprod
Biol. 2012; 165(1): 37-41.
30. Agostinis C, Bulla R, Tripodo C, Gismondi A, Stabile
H, Bossi F, et al. An alternative role of C1q in
cell migration and tissue remodeling: Contribution
to trophoblast invasion and placental development.
J Immunol. 2010; 185(7): 4420-4429.
31. Kouser L, Madhukaran SP, Shastri A, Saraon A,
Ferluga J, Al-Mozaini M, et al. Emerging and novel
functions of complement protein C1q. Front Immunol.
2015; 6: 317.
32. Singh J, Ahmed A, Girardi G. Role of complement
component C1q in the onset of preeclampsia in mice.
Hypertension. 2011; 58(4): 716-724.
|
|
|
|
 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
|
